Literature DB >> 8945928

Visualization of doxorubicin-induced oxidative stress in isolated cardiac myocytes.

N Sarvazyan1.   

Abstract

The paper presents high-resolution fluorescence images obtained using laser-scanning confocal microscopy. Isolated cells from adult rat hearts were preloaded with 2',7'-dichlorofluorescin (an oxidant-sensitive fluorescent probe) and exposed to doxo- rubicin, an important anticancer drug with prominent cardioxicity. Fluorescence images were collected from live cells simultaneously on two channels: 1) 515-530 nm emission range was used to monitor an increase in dichlorofluorescein, the oxidized product of dichlorofluorescein, and 2) emission > 610 nm was used to visualize the intracellular distribution of doxorubicin. The images reveal intracellular oxidation close to the mitochondria after only 20 min of exposure of isolated cardiomyocytes to 40-160 microM doxorubicin. The data confirm an oxidative mechanism of doxorubicin cardiotoxicity and demonstrate the capability of a new technique to monitor intracellular oxidation in living cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8945928     DOI: 10.1152/ajpheart.1996.271.5.H2079

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  31 in total

Review 1.  Manganese superoxide dismutase: beyond life and death.

Authors:  Aaron K Holley; Sanjit Kumar Dhar; Yong Xu; Daret K St Clair
Journal:  Amino Acids       Date:  2010-05-08       Impact factor: 3.520

2.  The TGF-β pathway mediates doxorubicin effects on cardiac endothelial cells.

Authors:  Zuyue Sun; Jill Schriewer; Mingxin Tang; Jerry Marlin; Frederick Taylor; Ralph V Shohet; Eugene A Konorev
Journal:  J Mol Cell Cardiol       Date:  2015-12-11       Impact factor: 5.000

3.  The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle.

Authors:  Laura A A Gilliam; Kelsey H Fisher-Wellman; Chien-Te Lin; Jill M Maples; Brook L Cathey; P Darrell Neufer
Journal:  Free Radic Biol Med       Date:  2013-09-07       Impact factor: 7.376

4.  Molecular biology of doxorubicin-induced cardiomyopathy.

Authors:  J Umlauf; M Horký
Journal:  Exp Clin Cardiol       Date:  2002

Review 5.  Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?

Authors:  Atocha Romero; Trinidad Caldés; Eduardo Díaz-Rubio; Miguel Martín
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

6.  Simple discrimination of sub-cycling cells by propidium iodide flow cytometric assay in Jurkat cell samples with extensive DNA fragmentation.

Authors:  Ramona Madalina Babes; Ioana Teodora Tofolean; Roxana Gabriela Sandu; Oana Elena Baran; Vlad Cosoreanu; Maria Teodora Ilie; Alexandru Ionut Duta; Maria Catalina Ceausescu; Paul Mihai Ciucur; Simona Costache; Constanta Ganea; Irina Baran
Journal:  Cell Cycle       Date:  2018-04-10       Impact factor: 4.534

Review 7.  Curbing cancer's sweet tooth: is there a role for MnSOD in regulation of the Warburg effect?

Authors:  Aaron K Holley; Sanjit Kumar Dhar; Daret K St Clair
Journal:  Mitochondrion       Date:  2012-07-20       Impact factor: 4.160

Review 8.  Doxorubicin-induced apoptosis: implications in cardiotoxicity.

Authors:  B Kalyanaraman; Joy Joseph; Shashi Kalivendi; Suwei Wang; Eugene Konorev; Srigiridhar Kotamraju
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

9.  Doxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-Q.

Authors:  Karunakaran Chandran; Deepika Aggarwal; Raymond Q Migrino; Joy Joseph; Donna McAllister; Eugene A Konorev; William E Antholine; Jacek Zielonka; Satish Srinivasan; Narayan G Avadhani; B Kalyanaraman
Journal:  Biophys J       Date:  2009-02-18       Impact factor: 4.033

10.  Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death.

Authors:  O Popelová; M Sterba; P Hasková; T Simůnek; M Hroch; I Guncová; P Nachtigal; M Adamcová; V Gersl; Y Mazurová
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.